BBC vs VHT

ABBC

BVHT

Measures won2–4VHT wins · of 6 · 5Y

$10,000 · 5Y$25,568XLE · VGT $20,649

Lowest cost0.08%XLE · $8 on $10k

Most income2.47%XLE · $247 on $10k

Smallest drop−10.4%VHT · worst fall in 1Y

Held in common2.4%BBC and VHT

BBC

VHT

Virtus Biotech Clinical Trials ETF · $27MVanguard Health Care ETF · $19.1B

+34.8%3 years · per year$24,485 · $15,781+16.4%

−0.0%5 years · per year$9,995 · $14,205+7.3%

0.65%Expense ratio$65 · $9 on $10k · lower wins0.09%

1.52%12-mo yield$152 · $135 on $10k1.35%

−30.2%Worst dropSmaller wins−10.4%

38.6%VolatilityLower wins16.3%

2–4VHT wins

$10,000 · 5 yearsAll four, one scale

Shared top holdingsBBC · VHT

0.9%RVMD0.5%

1.1%PCVX0.1%

0.8%PRAX0.1%

1.2%KYMR0.1%

Held in common2.4%

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Four

5Y4 funds

#
1	XLE	State Street Energy Select Sector SPDR ETFRead Desk	0.08%	2.47%	0.0%	+40.6%	+45.0%	+16.8%	+20.7%	−15.0%	$40.5B
2	VGT	Vanguard Information Technology ETFRead Desk	0.09%	0.44%	+1.4%	+15.6%	+12.1%	+28.6%	+15.6%	−17.5%	$154.5B
3	BVHT	Vanguard Health Care ETFRead Desk	0.09%	1.35%	0.0%	+19.8%	+27.4%	+16.4%	+7.3%	−10.4%	$19.1B
4	ABBC	Virtus Biotech Clinical Trials ETFRead Desk	0.65%	1.52%	+5.6%	+11.6%	+46.1%	+34.8%	0.0%	−30.2%	$27M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Four

5Y4 funds

#
1	XLE	State Street Energy Select Sector SPDR ETFRead Desk	0.08%	2.47%	0.0%	+40.6%	+45.0%	+16.8%	+20.7%	−15.0%	$40.5B
2	VGT	Vanguard Information Technology ETFRead Desk	0.09%	0.44%	+1.4%	+15.6%	+12.1%	+28.6%	+15.6%	−17.5%	$154.5B
3	BVHT	Vanguard Health Care ETFRead Desk	0.09%	1.35%	0.0%	+19.8%	+27.4%	+16.4%	+7.3%	−10.4%	$19.1B
4	ABBC	Virtus Biotech Clinical Trials ETFRead Desk	0.65%	1.52%	+5.6%	+11.6%	+46.1%	+34.8%	0.0%	−30.2%	$27M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

BBC vs VHT

BBC

Virtus Biotech Clinical Trials

$9,995

VHT

Vanguard Health Care

$14,205

MeasureBBCVHT

Fee0.65%0.09%

Cost on $10k a year$65$9

Yield1.52%1.35%

5 years, per year−0.0%+7.3%

3 years, per year+34.8%+16.4%

Worst drop · 1Y−30.2%−10.4%

Volatility · 1Y38.6%16.3%

4–2measures won
VHT first

2.4%

holdings shared

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

XLK vs VGT

YTD

SPDRXLK

+14.8%

VGTVanguard

+15.6%

+14.8%Year to date+15.6%

0.08% · $8Fee · on $10k a year0.09% · $9

$108BAssets$155B

1–1level

End-of-day Nov 6, 2026

XLE vs VDE

YTD

SPDRXLE

+40.6%

VDEVanguard

+38.6%

+40.6%Year to date+38.6%

2.5%Yield2.4%

$40.5BAssets$10.4B

2–0XLE wins

End-of-day Nov 6, 2026

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

Overlap: BBC, VHT, VGT, XLE

Today

2.4%most shared, BBC and VHT

BBCVHTVGTXLE

BBC—2.4%0.0%0.0%

VHT2.4%—0.0%0.0%

VGT0.0%0.0%—0.0%

XLE0.0%0.0%0.0%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$239most kept, XLE

XLE$247 − $8 = $239

VHT$135 − $9 = $126

BBC$152 − $65 = $87

VGT$44 − $9 = $35

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee